ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

R. J. Hicks, C. Dromain, W. W. de Herder, F. P. Costa, C. M. Deroose, A. Frilling, A. Koumarianou, E. P. Krenning, E. Raymond, L. Bodei, H. Sorbye, S. Welin, B. Wiedenmann, D. Wild, J. R. Howe, J. Yao, D. O’Toole, A. Sundin, V. Prasad*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
2 Downloads (Pure)


The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

Original languageEnglish
Article numbere13040
JournalJournal of Neuroendocrinology
Issue number3
Publication statusPublished - Mar 2022

Bibliographical note

Funding Information:
We thank the ENETS office staff, including Leah Matthews, Regine Reinstorf and Ulrike Knell, for their continuous support. Open Access funding enabled and organized by Projekt DEAL.

Publisher Copyright:
© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.


Dive into the research topics of 'ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours'. Together they form a unique fingerprint.

Cite this